← Leaderboards
Irving Sucholeiki
Aquilus Pharmaceuticals, Inc.
$3,562,237
Attributed
$3,562,237
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2011–19$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$3,562,237 · 6
By mechanism
R44$1,931,422 · 1
R43$1,630,815 · 5
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Oral”
- Daniel R Kuritzkes · Brigham And Women'S Hospital$236,409,338
- Judith S. Currier · University Of California Los Angeles$134,347,732
- Constance Ann Benson · University Of California, San Diego$123,741,444
- Wafaa M. El-Sadr · Columbia University Health Sciences$92,413,650
- Myron S Cohen · Family Health International$91,263,426
- Robert A Wood · Johns Hopkins University$57,641,510
Research focus
OralBiological AvailabilitySmall Business Innovation Research GrantInhibitor/AntagonistRodent ModelGelatinase ATissuesRunningPharmaceutical PreparationsPharmacologic SubstanceAnimal ModelClinicScale UpPainPainful NeuropathyMatrix Metalloproteinase InhibitorAnimal EfficacyAdverse EffectsPlasmaBiological MarkersDoseDrug KineticsMouse ModelRattus
Grant awards (7)
Matrix Metalloproteinase-2/-9 Inhibitor For The Treatment Of ALS$457,639
R43 · FY2019 · NS · contact PI
Development of a MMP Inhibitor for Neuropathic Pain$1,375,173
R44 · FY2016 · DE · contact PI
Development of a MMP Inhibitor for Neuropathic Pain$556,249
R44 · FY2015 · DE · contact PI
Orally active MMP inhibitor for the treatment of bone cancer pain$287,199
R43 · FY2015 · CA · contact PI
Metalloproteinase Inhibitor For Pain and Morphine Tolerance Due To Thermal Injury$261,982
R43 · FY2014 · GM · contact PI
Selective Matrix Metalloproteinase Inhibitors For Osteoarthritis$373,995
R43 · FY2012 · AG · contact PI
MMP Inhibitor For Orofacial Pain$250,000
R43 · FY2011 · DE · contact PI